Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationMultiple MyelomaHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorAntigens, CD34LeukapheresisHematologic NeoplasmsCombined Modality TherapyStem Cell TransplantationBlood Component RemovalCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseMyeloablative AgonistsStem CellsHematopoietic Stem CellsBusulfanTreatment OutcomeGraft SurvivalBone Marrow TransplantationLymphoma, Non-HodgkinEtoposideAntineoplastic Agents, AlkylatingThiotepaRemission InductionRecurrenceCarmustineCytophagocytosisCord Blood Stem Cell TransplantationSalvage TherapyIfosfamideVincristineAmyloidosisHematopoiesisDisease-Free SurvivalCytarabineTransplantation ChimeraHodgkin DiseaseRetrospective StudiesTissue DonorsNeoplasmsSurvival RateWhole-Body IrradiationSurvival AnalysisTime FactorsHistocompatibility TestingDoxorubicinHistocompatibilityInfectionLymphoma, T-CellPlatelet CountDexamethasoneBlood Cell CountPOEMS SyndromeTransplantation, IsogeneicPrednisoneLeukemia, Myeloid, AcuteImmunosuppressive AgentsLeukemiaCarboplatinAntineoplastic AgentsFollow-Up StudiesVidarabineRecombinant ProteinsBone Marrow PurgingLymphomaBlood CellsProspective StudiesFatal OutcomeEmbryonic Stem CellsCytomegalovirus InfectionsGraft vs Leukemia EffectFeasibility StudiesImmunophenotypingBone MarrowMyelodysplastic SyndromesAdult Stem CellsMesenchymal Stem Cell TransplantationLymphocyte DepletionHematologic DiseasesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAnemia, AplasticFlow CytometryT-LymphocytesBlood Transfusion, AutologousHLA AntigensPrognosisLiver TransplantationBone Marrow CellsCell SeparationLeukocytes, MononuclearBlood DonorsOpportunistic InfectionsCell DifferentiationPluripotent Stem Cells